Image de couverture de livre

Power and Sample Size Calculations for Bayes Factors in two-arm clinical Phase II Trials with binary Endpoints

Fuente: arXiv

Enregistré dans:

Détails bibliographiques
Auteur principal:	Kelter, Riko
Format:	Preprint
Publié:	2026
Sujets:	Methodology Applications
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Optimal sequential two-stage Bayes Factor Design for two-arm clinical Phase II Trials with binary Endpoints
par: Kelter, Riko
Publié: (2026)

Bayesian Power and Sample Size Calculations for Bayes Factors in the Binomial Setting
par: Kelter, Riko, et autres
Publié: (2025)

The Bayesian optimal two-stage design for clinical phase II trials based on Bayes factors
par: Kelter, Riko, et autres
Publié: (2025)

Robust Power and Sample Size Calculations in Quasi-likelihood Models: Methods and Practice
par: Yuan, Shijie, et autres
Publié: (2026)

Designing Efficient Hybrid and Single-Arm Trials: External Control Borrowing and Sample Size Calculation
par: Gao, Yujing, et autres
Publié: (2025)

Unified and Simple Sample Size Calculations for Individual or Cluster Randomized Trials with Skewed or Ordinal Outcomes
par: Tu, Shengxin, et autres
Publié: (2025)

BayesPPDSurv: An R Package for Bayesian Sample Size Determination Using the Power and Normalized Power Prior for Time-To-Event Data
par: Shen, Yueqi, et autres
Publié: (2024)

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
par: Maity, Arnab Kumar, et autres
Publié: (2024)

Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials
par: Long, James P., et autres
Publié: (2025)

A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
par: Gu, Xuemin, et autres
Publié: (2026)

Sample Size Calculations for the Development of Risk Prediction Models that Account for Performance Variability
par: Pavlou, Menelaos, et autres
Publié: (2025)

Toward Valid Generative Clinical Trial Data with Survival Endpoints
par: Chassat, Perrine, et autres
Publié: (2025)

Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
par: Zhang, Hong, et autres
Publié: (2023)

Sample Size Calculations for Developing Clinical Prediction Models: Overview and pmsims R package
par: Shamsutdinova, Diana, et autres
Publié: (2026)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
par: Komaki, Moka, et autres
Publié: (2025)

A non-parametric U-statistic testing approach for multi-arm clinical trials with multivariate longitudinal data
par: Ghosh, Dhrubajyoti, et autres
Publié: (2024)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
par: Zhu, Di, et autres
Publié: (2026)

Comparison of Simulation-Guided Design to Closed-Form Power Calculations in Planning a Cluster Randomized Trial with Covariate-Constrained Randomization: A Case Study in Rural Chad
par: Park, Jay JH, et autres
Publié: (2025)

Evaluation of Surrogate Endpoints Based on Meta-Analysis with Surrogate Indices
par: Stijven, Florian, et autres
Publié: (2025)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
par: Hall, Andrew, et autres
Publié: (2025)

Sample Size Selection under an Infill Asymptotic Domain
par: Natoli, Cory W., et autres
Publié: (2024)

Covariate Ordered Systematic Sampling as an Improvement to Randomized Controlled Trials
par: Jobson, Deddy, et autres
Publié: (2024)

Behavioral Carry-Over Effect and Power Consideration in Crossover Trials
par: Shi, Danni, et autres
Publié: (2023)

Eliciting prior information from clinical trials via calibrated Bayes factor
par: Demartino, Roberto Macrì, et autres
Publié: (2024)

Sample Design and Cross-sectional Weights for the Brazilian PCSVDF-Mulher Study: Integrating a Refreshment Sample with an Ongoing Longitudinal Wave to Calculate IPV Prevalence
par: Carvalho, José Raimundo, et autres
Publié: (2023)

Optimal and Efficient Sample Size Re-estimation: A Dynamic Cost Framework
par: Jin, Rui, et autres
Publié: (2025)

Bayesian Functional Analysis for Untargeted Metabolomics Data with Matching Uncertainty and Small Sample Sizes
par: Ma, Guoxuan, et autres
Publié: (2023)

Tutorial for Surrogate Endpoint Validation Using Joint modeling and Mediation Analysis
par: Coent, Quentin Le, et autres
Publié: (2025)

Closed-Form Power and Sample Size Calculations for Bayes Factors
par: Pawel, Samuel, et autres
Publié: (2024)

Evaluating the impact of outcome delay on the efficiency of two-arm group-sequential trials
par: Mukherjee, Aritra, et autres
Publié: (2023)

Multi-Dimensional Composite Endpoint Analysis via the Choquet Integral: Block Recurrent Encoding and Comparative Advantage Mapping
par: Tanboga, Ibrahim Halil
Publié: (2026)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
par: Chen, Yuxuan, et autres
Publié: (2026)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
par: Lee, Kyong Ju, et autres
Publié: (2025)

The FORSS Framework for Sample Size and Power Calculations With Win Statistics for Hierarchical Endpoints
par: Zhang, Baoshan, et autres
Publié: (2026)

A multi-arm multi-stage design for trials with all pairwise testing
par: Greenstreet, Peter, et autres
Publié: (2025)

Increasing power and robustness in screening trials by testing stored specimens in the control arm
par: Katki, Hormuzd A., et autres
Publié: (2024)

MUCE: Bayesian Hierarchical Modeling for the Design and Analysis of Phase 1b Multiple Expansion Cohort Trials
par: Lyu, Jiaying, et autres
Publié: (2020)

Cumulative Logit Ordinal Regression with Proportional Odds under Nonignorable Missing Response -- Application to Phase III Trial
par: Maity, Arnab Kumar, et autres
Publié: (2025)

TAD-SIE: Sample Size Estimation for Clinical Randomized Controlled Trials using a Trend-Adaptive Design with a Synthetic-Intervention-Based Estimator
par: Lala, Sayeri, et autres
Publié: (2024)

Bayes Factor of Zero Inflated Models under Jeffereys Prior
par: Pramanik, Paramahansa, et autres
Publié: (2024)